List your tool

Head to head · 2026

Bioptimus vs PathAI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Bioptimus

Foundation models for biology spanning molecular, cellular and tissue scales

4.2Not listed

Visit Bioptimus (opens Bioptimus in a new tab)

PathAI

First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp

4.3Not listed

Visit PathAI (opens PathAI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Bioptimus does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    PathAI

    4.2 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onBioptimusPathAI
Our rating4.24.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Foundation models trained across molecular, cellular and tissue scales
  • Digital pathology models for research and trial workflows
  • Transfer learning that reuses existing imaging and omics archives
  • Benchmarked against independent public evaluations
  • Research, clinical trial and diagnostics use cases
  • AISight Dx analyzes digital pathology slide images to assist diagnosis
  • FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
  • Predetermined Change Control Plan allows faster future software updates
  • Expanded Labcorp collaboration deploying nationwide as of February 2026
  • FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
Pros
  • Cross-scale model design rather than one narrow task classifier
  • Extracts additional value from data a lab already holds
  • Published benchmark results give an external reference point
  • Genuine FDA clearance for primary diagnosis, not just an assistive tool
  • Predetermined Change Control Plan speeds up future regulatory-approved updates
  • National-scale deployment through Labcorp validates real clinical trust
Cons
  • Requires in-house validation on local cohorts before clinical reliance
  • Enterprise-only engagement with no self-serve access
  • Enterprise quote-based pricing requires a sales conversation, no published rates
  • Built specifically for pathology labs, not applicable to other clinical specialties
  • Regulatory-cleared medical device status means slower iteration than software-only tools
CompanyBioptimus, founded 2024PathAI, founded 2016

Prices come from each vendor's pricing page, last checked 20260812. Check the vendor before you buy.

FAQ

Questions people ask

Is Bioptimus better than PathAI?

In our reviews Bioptimus scores 4.2 and PathAI scores 4.3. The better pick depends on the job. Bioptimus: Foundation models for biology spanning molecular, cellular and tissue scales. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.

Which is cheaper, Bioptimus or PathAI?

Bioptimus: see pricing. PathAI: see pricing.

Do Bioptimus and PathAI have free plans?

Neither lists a free plan.

More comparisons

Bioptimus compared with

All Bioptimus alternatives

PathAI compared with

All PathAI alternatives